Loading stock…

Oracle Corporation (ORCL) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

ORCLOracle

Revenue FY26$67.4B

GROWTH RATING↗

VERY STRONG96 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y+34%9

Revenue, next 3Y, CAGR+40%10

Revenue, next 5Y, CAGR+31%10

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+37%9

EPS growth, FY28E+36%9

EPS growth, FY29E+46%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 96% of companies worldwide.

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Revenue is set to grow 40%/yr over the next 3 years, ahead of most of the market.10/10

Revenue grew 10%/yr over the last 3 years and is set to grow 40%/yr from here.

The runway holds up: revenue is set to grow 31%/yr over five years.10/10

Earnings are set to grow in step with sales (EPS about 37%/yr vs revenue 40%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK23 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return+3%7

YTD return-25%2

MID & LONG-TERM▾SCORE

% of 52-week high45%1

1-year return-48%1

3-year return+36%5

5-year return+68%6

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+3%).

WATCH

Average long-term results. Multi-year returns are middling (+36% over three years and +68% over five), roughly average for the market.

WEAKNESSES

It's down 48% over the past year, now 55% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-9%) and so far this year (-25%).

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Oracle. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ORCLOracle

Revenue FY26$67.4B

GROWTH RATING↗

VERY STRONG96 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+10%7

Revenue, next 1Y+34%9

Revenue, next 3Y, CAGR+40%10

Revenue, next 5Y, CAGR+31%10

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+37%9

EPS growth, FY28E+36%9

EPS growth, FY29E+46%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 96% of companies worldwide.

Revenue grew 10%/yr over the last 3 years, ahead of 60% of companies worldwide.7/10

Revenue is set to grow 40%/yr over the next 3 years, ahead of most of the market.10/10

Revenue grew 10%/yr over the last 3 years and is set to grow 40%/yr from here.

The runway holds up: revenue is set to grow 31%/yr over five years.10/10

Earnings are set to grow in step with sales (EPS about 37%/yr vs revenue 40%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

WEAK23 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return+3%7

YTD return-25%2

MID & LONG-TERM▾SCORE

% of 52-week high45%1

1-year return-48%1

3-year return+36%5

5-year return+68%6

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over three months (+3%).

WATCH

Average long-term results. Multi-year returns are middling (+36% over three years and +68% over five), roughly average for the market.

WEAKNESSES

It's down 48% over the past year, now 55% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-9%) and so far this year (-25%).

BOTTOM LINE

Weak Tape

Returns across short and long horizons rank poorly versus the market. Momentum offers no support here; the case has to come from other factors. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Oracle. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Oracle Corporation

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Oracle. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Oracle. Get the full investment case.

Premium